查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2033201

醣質學市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034年

Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年全球醣質學市場規模為19億美元。展望未來，IMARC Group預測，該市場將以10.19%的複合年成長率從2026年成長至2034年，到2034年達到47億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過39.1% 。醣質學市場佔有率的擴張主要歸因於慢性病發病率的上升、糖技術研究的日益普及以及參與製藥和生技藥品的合約研究組織（CRO）數量的增加。

醣質學是一門專注於全面研究生物系統中碳水化合物（尤其是聚醣）的科學領域。其目標是了解聚醣的結構、組成、功能以及與其他生物分子的相互作用。透過分析糖組學數據，研究人員可以揭示聚醣如何影響生物過程以及它們如何與健康和疾病相關。這個交叉學科融合了化學、生物化學、分子生物學和資訊科學等學科的知識，旨在揭示聚醣結構和功能的複雜性。這項研究獲得的見解對包括醫學、藥物研發、生物標記發現和個人化醫療在內的許多領域具有重要意義。

全球市場的主要驅動力是慢性病盛行率的不斷上升。此外，人們對Glico日益成長的興趣也推動了市場發展。Glico是一種透過修飾或操控糖鏈來開發各種應用（包括治療、疫苗和生物技術）的技術。同時，各國政府、研究機構和私人投資者都認知到醣質學在推進醫學和生物技術發展方面的潛力，並投資進行深入研究、開發新技術以及探索基於醣質學產品的商業化，這進一步促進了市場成長。糖組學在全球教育和培訓領域也越來越受歡迎。此外，參與藥品和生技藥品研發生產的合約研究組織（CRO）數量的增加也推動了市場成長。其他因素，例如製藥業的擴張、臨床試驗數量的增加以及醫療基礎設施的進步，也正在影響市場。

醣質學市場的發展趨勢與促進因素：

研發活動活性化

市場研發活動正經歷顯著成長。隨著我們對聚醣在各種生物過程中關鍵作用的理解不斷加深，研究和操控這些分子的興趣也日益濃厚。研究人員和製藥公司正加大投入，探索聚醣在藥物發現、個人化醫療和診斷領域的潛在應用。此外，分析方法和技術的不斷進步也推動了研究範圍的擴展。同時，學術界、產業界和研究機構之間的合作也促進了醣質學組學研發的發展。這種合作匯集了多元化的專業知識和資源，促進了創新，並加速了基於醣質學產品的開發。此外，各相關人員的合作努力也有助於知識的拓展、新技術的開發、研究成果的實用化。

對個人化醫療的需求日益成長

個人化醫療旨在根據患者的基因組成和特定特徵，為每位患者量身定做最佳化醫療方案，目前正受到越來越多的關注。醣類被認為與多種疾病相關，並可作為潛在的生物標記物用於診斷和預後預測，因此在個人化醫療中發揮著至關重要的作用。分析和理解患者的糖組學特徵，有助於開發標靶治療和更精準的醫療干預措施。此外，醣質學分析技術的進步，例如糖晶片和糖定序，使得識別疾病特異性糖特徵變得更加容易。這些發現有望推動基於糖的診斷、個人化療法和伴隨診斷的發展，進一步提升對醣質學研究和產品的需求。

人們越來越關注生物標記的發現

醣質學在生物標記發現領域備受關注。聚醣作為多種疾病（包括癌症、心血管疾病和感染疾病）的生物標記展現出巨大的潛力。生物標記在疾病診斷、預後和療效監測中發揮著至關重要的作用。此外，人們對生物標記發現的興趣日益濃厚，推動了相關研究的需求，因為識別可靠且特異性的生物標記對於改善疾病檢測、患者分層和治療方法選擇至關重要。將醣質學整合到生物標記發現流程中，有望革新診斷方法並實現早期療育，從而推動整體市場成長。這項研究也為識別與各種疾病相關的特定聚醣模式和變化提供了獨特的機會。透過研究個體和患者群體的醣組，研究人員可以揭示疾病特異性的聚醣特徵，這些特徵可作為診斷和預後預測的生物標記。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球醣質學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 酵素
    • 主要部分
      • 糖苷酶
      • 糖基轉移酶
      • 神經氨酸酶
      • 唾液酸轉移酶
      • 其他
  • 裝置
    • 主要部分
      • 質譜儀
      • HPLC
      • MALDI-TOF
      • 陣列系統
      • 其他
  • 成套工具
    • 主要部分
      • 聚醣標記試劑盒
      • 聚醣純化試劑盒
      • 糖釋放試劑盒
      • 其他
  • 試劑
    • 主要部分
      • 糖蛋白
      • 單醣
      • 寡糖
      • 其他

第7章 市場區隔：依應用領域分類

  • 藥物發現與開發
  • 診斷
  • 其他

第8章 市場區隔：依最終用戶分類

  • 學術研究機構
  • 製藥和生物技術公司
  • 受託研究機構（CRO）

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Danaher Corporation
    • Dextra Laboratories Limited（New Zealand Pharmaceuticals Limited）
    • Merck KGaA
    • New England Biolabs
    • RayBiotech Life Inc.
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112026A5689

The global glycomics market size was valued at USD 1.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.7 Billion by 2034, exhibiting a CAGR of 10.19% from 2026-2034. North America currently dominates the market, holding a market share of over 39.1% in 2025. The glycomics market share is rising due to the growing incidence of chronic diseases, rising focus on glycoengineering techniques, and increasing number of contract research organizations (CROs) involved in drug and biologics.

Glycomics is a scientific field that focuses on the comprehensive study of carbohydrates, specifically glycans, in biological systems. It aims to understand the structure, composition, and functions of glycans, as well as their interactions with other biomolecules. By analyzing the glycome, researchers can determine how glycans influence biological processes and contribute to health and disease. This interdisciplinary field combines aspects of chemistry, biochemistry, molecular biology, and informatics to unravel the complexities of glycan structures and functions. The insights gained from the research have implications across various domains, including medicine, drug development, biomarker discovery, and personalized therapeutics.

The global market is primarily driven by the growing prevalence of chronic diseases. Moreover, the increasing focus on glycoengineering is supporting the market as glycoengineering involves the modification or manipulation of glycans for various applications, including therapeutics, vaccines, and biotechnology. Apart from this, Governments, research organizations, and private investors are recognizing the potential of glycomics in advancing healthcare and biotechnology and are providing investments to conduct in-depth studies, develop new technologies, and explore the commercialization of glycomics-based products, providing a boost to the market. Furthermore, it is gaining popularity in the field of education and training worldwide. Additionally, the growing number of contract research organizations (CROs) involved in drug and biologics development and production is augmenting the market growth. Other factors, such as expanding pharmaceutical industry, increasing number of clinical trials, and advancements in healthcare infrastructure, are also influencing the market.

Glycomics Market Trends/Drivers:

Increasing Research and Development Activities

The market is experiencing a significant boost in research and development (R&D) activities. The growing understanding of the crucial roles played by glycans in various biological processes has increased interest in studying and manipulating these molecules. Researchers and pharmaceutical companies are investing in research to explore the potential applications of glycans in drug discovery, personalized medicine, and diagnostics. Moreover, the expanding scope of the research is driven by continuous advancements in analytical techniques and technologies. Furthermore, collaborations between academia, industry, and research institutions have fueled the growth of glycomics R&D. These collaborations bring together diverse expertise and resources, fostering innovation and accelerating the development of glycomics-based products. Additionally, the collaborative efforts between various stakeholders contribute to the expansion of knowledge, development of new technologies, and translation of research findings into practical applications.

Rising Demand for Personalized Medicine

Personalized medicine, which aims to tailor medical treatments to individual patients based on their genetic makeup and specific characteristics, is gaining prominence. It plays a pivotal role in personalized medicine as glycans have been implicated in various diseases and can serve as potential biomarkers for diagnostics and prognostics. The ability to analyze and understand the glycome of patients can enable the development of targeted therapies and more precise medical interventions. In addition, the advancements in glycomics profiling technologies, such as glycan microarrays and glycan sequencing, have facilitated the identification of disease-specific glycan signatures. These discoveries hold promise for the development of glycan-based diagnostics, personalized therapeutics, and companion diagnostics, further fueling the demand for glycomics research and products.

Increasing Focus on Biomarker Discovery

Glycomics has gained significant attention in the field of biomarker discovery. Glycans have shown promising potential as biomarkers for various diseases, including cancer, cardiovascular disorders, and infectious diseases. Biomarkers play a crucial role in disease diagnosis, prognosis, and monitoring treatment efficacy. Moreover, the growing focus on biomarker discovery has propelled the demand for research, as the identification of reliable and specific biomarkers is crucial for improving disease detection, patient stratification, and treatment selection. Furthermore, the integration of glycomics into biomarker discovery pipelines has the potential to revolutionize diagnostics and enable early intervention, driving the growth of the overall market. Also, the research offers a unique opportunity to identify specific glycan patterns or alterations associated with different diseases. By studying the glycome of individuals or patient cohorts, researchers can unveil disease-specific glycan signatures that can serve as diagnostic or prognostic biomarkers.

Glycomics Industry Segmentation:

This report provides an analysis of the key trends in each segment of the global glycomics market, along with forecasts at the global, regional, and country levels from 2026-2034. The market has been categorized based on product, application, and end user.

Breakup by Product:

  • Enzymes
  • Glycosidases
  • Glycosyltransferases
  • Neuraminidases
  • Sialyltransferases
  • Others
  • Instruments
  • Mass Spectrometers
  • HPLC
  • MALDI-TOF
  • Array systems
  • Others
  • Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Glycan Release Kits
  • Others
  • Reagents
  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides
  • Others

Enzymes equipment dominates the market

On the basis of the product, enzymes represent the largest product segment within the market. Enzymes play a crucial role in research and applications by facilitating the analysis and manipulation of glycans. Enzymes, such as glycosidases, glycosyltransferases, and glycosyl hydrolases, are utilized in various workflows, including glycan release, structural analysis, and glycan modification. Moreover, enzymes are essential for the enzymatic cleavage of glycans from glycoproteins or glycolipids, enabling the analysis of liberated glycans. The demand for enzymes in research and applications is driven by the growing need for robust and efficient enzymatic tools. Researchers and scientists rely on enzymes to accurately and selectively manipulate glycans, enabling comprehensive glycomics analysis and the development of glycan-based products. Additionally, advancements in enzyme engineering and optimization have led to the development of highly specific and efficient enzymes, further enhancing their utility in glycomics research.

Breakup by Application:

  • Drug Discovery and Development
  • Diagnostics
  • Others

Drug discovery and development hold the largest share in the market

On the basis of application, drug discovery and development represent the largest segment within the overall market. It plays a crucial role in advancing drug discovery and development processes by providing insights into the role of glycans in disease mechanisms, drug efficacy, and safety. Glycans are involved in various biological processes and have been linked to numerous diseases, including cancer, cardiovascular disorders, and infectious diseases. Understanding the glycan profiles and their interactions with proteins and cells is essential for identifying potential therapeutic targets and designing effective drugs. Moreover, the integration with drug discovery and development processes has led to the development of glycan-based therapies, companion diagnostics, and improved drug screening platforms. Also, the focus on targeting glycans in drug discovery and development has driven the demand for research and technologies, making it the largest application segment within the market.

Breakup by End User:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

Academic and research institutes hold the largest share in the market

Academic and research institutes represent the largest segment of the market. They play a vital role in driving research and advancements in the field. These institutions serve as the primary hubs for scientific research, knowledge generation, and innovation in the field. They are home to leading scientists, researchers, and experts who are actively involved in studying and exploring the complexities of glycans. These institutions also provide the necessary infrastructure, funding, and collaborative opportunities to support the research. They often house state-of-the-art laboratories equipped with advanced analytical instruments and technologies, enabling comprehensive glycan analysis and profiling. Furthermore, academic and research institutes contribute significantly to expanding the knowledge base through publications, scientific conferences, and collaborations. They foster interdisciplinary research collaborations, bringing together experts from various fields such as chemistry, biology, bioinformatics, and medicine.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest glycomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the market. North America is home to several renowned academic institutions, research organizations, and biotechnology companies that have made significant contributions to the research. These institutions have robust research infrastructure, state-of-the-art laboratories, and well-established collaborations, facilitating cutting-edge studies and innovation. Moreover, the region has a well-developed healthcare and biopharmaceutical sector, which drives the demand for research and applications. The presence of major pharmaceutical companies and biotech firms in North America leads to significant investments in the research for drug discovery, personalized medicine, and the development of glycan-based therapeutics. Furthermore, the region has a favorable regulatory environment and strong intellectual property protections that encourage innovation and commercialization of glycomics-based products. The region's well-defined regulatory frameworks provide clarity and guidance for research, ensuring the safety and efficacy of glycan-based diagnostics and therapeutics.

Competitive Landscape:

Companies in the market are involved in various activities related to glycomics research, product development, and commercialization. Several major companies are investing in research and development to advance the understanding of glycans, develop new technologies, and explore applications in various fields. They conduct studies to uncover the roles of glycans in disease mechanisms, identify glycan biomarkers, and understand glycan-protein interactions. Moreover, the companies in the market develop and manufacture products that support the research. This includes enzymes, kits, reagents, and instruments used in glycan analysis, glycan profiling, and glycan modification. These products help researchers in academia, pharmaceutical companies, and research institutes carry out glycomics experiments and investigations. Additionally, some companies focus on translating research into commercial applications. They develop and market glycan-based products for various industries, such as biopharmaceuticals, diagnostics, and nutraceuticals.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Asparia Glycomics
  • Bruker Corporation
  • Danaher Corporation
  • Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
  • Merck KGaA
  • New England Biolabs
  • RayBiotech Life Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation.

Key Questions Answered in This Report

1. How big is the glycomics market?

2. What is the future outlook of glycomics market?

3. What are the key factors driving the glycomics market?

4. Which region accounts for the largest glycomics market share?

5. Which are the leading companies in the global glycomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Glycomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Enzymes
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Glycosidases
      • 6.1.2.2 Glycosyltransferases
      • 6.1.2.3 Neuraminidases
      • 6.1.2.4 Sialyltransferases
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Mass Spectrometers
      • 6.2.2.2 HPLC
      • 6.2.2.3 MALDI-TOF
      • 6.2.2.4 Array systems
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Kits
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Glycan Labeling Kits
      • 6.3.2.2 Glycan Purification Kits
      • 6.3.2.3 Glycan Release Kits
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Reagents
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Glycoproteins
      • 6.4.2.2 Monosaccharides
      • 6.4.2.3 Oligosaccharides
      • 6.4.2.4 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Academic and Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Asparia Glycomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 New England Biolabs
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 RayBiotech Life Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Shimadzu Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Waters Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Glycomics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Glycomics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Glycomics Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Glycomics Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Glycomics Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Glycomics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Glycomics (Enzymes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Glycomics (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Glycomics (Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Glycomics (Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Glycomics (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Glycomics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: North America: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: North America: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: United States: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: United States: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Canada: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Canada: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Asia-Pacific: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: China: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: China: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Japan: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Japan: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: India: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: India: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: South Korea: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: South Korea: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Australia: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Australia: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Indonesia: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Indonesia: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Others: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Germany: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Germany: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: France: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: France: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United Kingdom: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United Kingdom: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Italy: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Italy: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Spain: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Spain: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Russia: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Russia: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Latin America: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Latin America: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Brazil: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Brazil: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Mexico: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Mexico: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Middle East and Africa: Glycomics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2025
  • Figure 75: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Global: Glycomics Industry: SWOT Analysis
  • Figure 77: Global: Glycomics Industry: Value Chain Analysis
  • Figure 78: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Glycomics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Glycomics Market: Competitive Structure
  • Table 7: Global: Glycomics Market: Key Players